Hemerus Medical LLC, Techne deal

TECH paid $3 million for a 10% interest in Hemerus, which has technology to produce leukoreduced blood for blood transfusion. Also, TECH subsidiary R&D Systems (Minneapolis, Minn.) formed a joint vent...